Lantheus Holdings Inc.

20/08/2024 | Press release | Distributed by Public on 20/08/2024 12:36

Lantheus to Present Additional Clinical Data from Phase 3 Pivotal SPLASH Trial in PSMA Positive Metastatic Castration Resistant Prostate Cancer During ESMO Congress 2024